×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: gilead | coronavirus | drug | biotech | stock | shares | rally

Gilead's Coronavirus Drug Success Spurs Biotech Stocks to Outperform

Gilead's Coronavirus Drug Success Spurs Biotech Stocks to Outperform
(Motortion/Dreamstime)

Wednesday, 29 April 2020 01:08 PM EDT

Gilead Sciences Inc.’s pair of promising announcements for its Covid-19 drug candidate, remdesivir, sparked a further rally in biotechnology stocks that have already been on a tear over the past month and a half.

The iShares Nasdaq Biotechnology exchange traded fund, ticker IBB, jumped as much as 4.2% in early trading Wednesday, on pace to open near the highest level since 2015. The pop came in the wake of two announcements from Gilead that studies of remdesivir benefited patients stricken by the novel coronavirus.

The early morning rally has the IBB on track to extend what has been a 32% snap-back from a March 16 low. That advance compares to a 20% gain for the S&P 500 over that same stretch as investors continue to put money to work. An equal-weighted ETF tracked by specialists, the SPDR S&P Biotech ETF (XBI), rose 3% at 9:00 a.m. Eastern time.

Biotechnology -- and the healthcare sector more broadly -- has been red-hot this year as investors look for ways to play the fight against the coronavirus pandemic.

Read more: Overheated Health-Care Stock Rally Starts to Draw Early Warnings

Gilead shares surged 9% as trading resumed after the announcements. Small-cap BioCryst Pharmaceuticals Inc. jumped as much as 34% after the Gilead announcement. The company is studying galidesivir, a drug that works in a similar way to remdesivir, in Covid-19 patients.

© Copyright 2024 Bloomberg News. All rights reserved.


InvestingAnalysis
Gilead Sciences Inc.’s pair of promising announcements for its Covid-19 drug candidate, remdesivir, sparked a further rally in biotechnology stocks that have already been on a tear over the past month and a half.
gilead, coronavirus, drug, biotech, stock, shares, rally
227
2020-08-29
Wednesday, 29 April 2020 01:08 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved